Cancer
The latest news on cancer diagnostics, liquid biopsy, and cancer risk testing.
A new publication detailing ctDNA testing results has spurred a minimal residual disease biomarker-directed trial for Roche's atezolizumab in bladder cancer.
Saga Diagnostics, University College London Cancer Institute Widen Cancer Collaboration
Saga will use its digital PCR-based SagaSafe assays to analyze hundreds of clinical tissue samples from the TRACERx and PEACE studies.
Epizyme Partnering With Quest Diagnostics for Lymphoma Mutation Testing
The companies have launched an initiative to improve patient access to EZH2Â mutation testing for patients with relapsed or refractory follicular lymphoma.
The company's technology measures 500 different volatile organic compounds to detect infectious diseases and cancer with real-time results.
Personal Genome Diagnostics Inks Cancer Genomic Profiling Deal with Duke University Health System
Under the deal, DUHS will establish PGDx's next-generation sequencing-based Elio Tissue Complete platform for the genomic profiling of cancer in its lab.